

Get More Info From DiaSorin: Molecular Diagnostics
Flexibility in Syndromic testing.
About Our Organization
Diasorin: The Diagnostic Specialist
Diasorin elevates your diagnostic stewardship initiatives with comprehensive molecular & immunodiagnostic solutions for infectious disease testing.
The LIAISON PLEX® bloodstream infection portfolio (BSI) features three FDA-cleared multiplex molecular assays, offering comprehensive pathogen detection for 48 bacterial and fungal species associated with bloodstream infections and sepsis, and 12 clinically significant antimicrobial resistance genes, enabling physicians to optimize antimicrobial treatment in a timely manner, improve patient management, and potentially reduce hospital costs.
Our LIAISON PLEX® BSI portfolio is intuitively designed to ensure seamless integration into your standard-of-care workflow. Guided by Gram stain results, they empower healthcare professionals to make informed decisions, streamline testing, and tailor diagnostics to meet patient-specific needs.
The Simplexa® C. auris Direct assay is the first FDA De Novo-granted assay for the qualitative in vitro detection of Candida auris colonization. This sample-to-answer test utilizes a simplified workflow to offer results in under 2 hrs, providing pivotal and timely aid in the prevention and control of a rapidly emerging multidrug-resistant fungal pathogen.
Our extensive immunodiagnostics portfolio of infectious disease assays includes the LIAISON® MeMed BV®, which provides rapid and reliable differentiation of bacterial and viral infections. This immune-based protein signature test integrates the levels of 3 host-proteins with a proprietary algorithm to deliver a fast, accurate, and easy-to-interpret score, indicating the likelihood of a bacterial or viral infection.
Our expansive portfolio empowers clinicians with the options they need to provide accurate, clinically relevant results.
Downloadable Handouts
-
C. auris Direct DetectionYou must log in to access content.
Booth Staff


There are no matching speakers.
Access Date | Quiz Result | Score | Actions |
---|